Ipad and the cloud: Further roll out of digital health hub

NHSX: Combining the best talent from government, the NHS and industry

A new joint unit, NHSX, will be created to bring the benefits of modern technology to every patient and clinician. It will combine the...
Trial results of Brilinta for heart attack patients following thrombolysis shows it met safety endpoint in secondary analysis of Phase III TREAT trial

Health matters: preventing cardiovascular disease

The Department of Health and Social Care has published a new professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation,...
Dementia drug discovery consortium

New partners join £9.5 million dementia drug discovery collaboration

The Dementia Consortium welcomes Johnson & Johnson Innovation, Takeda and Evotec to join the unique £9.5 million dementia drug discovery collaboration. This second phase...
illegal market sharing over anti-nausea tablets

New antibiotic prescribing guidance for patients with suspected pneumonia 

The National Institute for Health and Care Excellence and Public Health England have published new antibiotic prescribing guidance for patients with suspected pneumonia. These...
Alzheimer's Society says women should not be alarmed over small hormone therapy risk.

Diagnosing Lyme disease if bull’s eye rash is present – NICE quality standard

Doctors should be diagnosing Lyme disease if bull’s eye rash is present, says NICE as it launches its Lyme disease NICE quality standard consultation. The...
The Topol Review and innovative technologies in the NHS

The Topol Review: Preparing the healthcare workforce to deliver the digital future

The Topol Review: Preparing the healthcare workforce to deliver the digital future has been published and it makes recommendations to enable NHS staff to...
new recommendation can delay chemotherapy for women with advanced breast cancer

Research into chemotherapy dose intensity and breast cancer

New research into chemotherapy dose intensity and breast cancer finds that giving chemotherapy drugs every two weeks instead of the usual every three weeks...
bottles of medicine affordable and innovative medicines

Competition enforcement contributes to affordable and innovative medicines

The European Commission has published a report showing that active competition law enforcement, at EU and national level, in the pharmaceutical sector contributes to...
Novartis announces Aimovig®▼ (erenumab) accepted for use by the Scottish Medicines Consortium for the prevention of chronic migraine

Origins of depression brought into focus in large-scale gene study

The origins of depression have been brought into focus in a large-scale gene study, involving more than two million people. Hundreds of genes have been newly-linked...
Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment

Mapping oesophageal cancer genes leads to new drug targets

Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail – unveiling that many could be targeted by drugs currently in trials...

Latest articles

GSK has announced changes to its sales representative incentive programme for representatives in certain countries

Changes to GSK sales representative incentive programme

GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
UK's first free mental health app has gone live

Peer-to-peer mental health support app goes live

The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
illegal market sharing over anti-nausea tablets

Drug firms accused of illegal market sharing over anti-nausea tablets

The Competitions and Markets Authority (CMA) has accused four pharmaceutical companies of illegal market sharing over anti-nausea tablets. The CMA has provisionally found that the pharmaceutical...

Popular articles

UK's first free mental health app has gone live

Peer-to-peer mental health support app goes live

The UK's first free peer-to-peer mental health support app, 'Unmasked', has gone live after a period of extensive testing. The brainchild of three Yorkshiremen, Logan...
NICE issues final guidance for Tegsedi ®▼

NICE issues final guidance for Tegsedi ®▼

Akcea Therapeutics UK Ltd, an affiliate of Akcea Therapeutics, Inc announced that the National Institute for Health and Care Excellence (NICE) has published its...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
GSK has announced changes to its sales representative incentive programme for representatives in certain countries

Changes to GSK sales representative incentive programme

GSK has announced changes to its sales representative incentive programme for representatives in certain countries. These changes reflect the growing shift in GSK’s portfolio...
Wasdell Group announces acquisition of Honeywood Limited

Wasdell Group expands portfolio with Honeywood acquisition

The Wasdell Group (Wasdell), a leading outsourcing partner for companies in the pharmaceutical industry, has announced its acquisition of Honeywood Limited, a specialist manufacturer...